Sonoma Pharmaceuticals, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Accounts Receivable

12 Months Ended

Mar. 31, 2025

NOTE 4 – Accounts Receivable

Accounts receivable, net consists of the following:

Schedule of accounts receivable
	March 31,
	2025			2024
Accounts receivable	$	2,240,000		$	2,925,000
Less: discounts, rebates, distributor fees and returns		(8,000	)		(27,000	)
Total accounts receivable, net	$	2,232,000		$	2,898,000